BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30215611)

  • 1. Evaluating nanomedicine with microfluidics.
    He Z; Ranganathan N; Li P
    Nanotechnology; 2018 Dec; 29(49):492001. PubMed ID: 30215611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine.
    Chen X; Zhang YS; Zhang X; Liu C
    Bioact Mater; 2021 Apr; 6(4):1012-1027. PubMed ID: 33102943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-on-a-chip model for advancement of anti-cancer nano drug delivery system.
    Tian C; Zheng S; Liu X; Kamei KI
    J Nanobiotechnology; 2022 Jul; 20(1):338. PubMed ID: 35858898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ-on-a-Chip: A Preclinical Microfluidic Platform for the Progress of Nanomedicine.
    Rodrigues RO; Sousa PC; Gaspar J; Bañobre-López M; Lima R; Minas G
    Small; 2020 Dec; 16(51):e2003517. PubMed ID: 33236819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation.
    Gimondi S; Ferreira H; Reis RL; Neves NM
    ACS Nano; 2023 Aug; 17(15):14205-14228. PubMed ID: 37498731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic-Based Platform for the Evaluation of Nanomaterial-Mediated Drug Delivery: From High-Throughput Screening to Dynamic Monitoring.
    Yang Y; Liu S; Geng J
    Curr Pharm Des; 2019; 25(27):2953-2968. PubMed ID: 31362686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic technologies for accelerating the clinical translation of nanoparticles.
    Valencia PM; Farokhzad OC; Karnik R; Langer R
    Nat Nanotechnol; 2012 Oct; 7(10):623-9. PubMed ID: 23042546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantum dots from microfluidics for nanomedical application.
    Bian F; Sun L; Cai L; Wang Y; Zhao Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Sep; 11(5):e1567. PubMed ID: 31257723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translational Nanomedicines Across Human Reproductive Organs Modeling on Microfluidic Chips: State-of-the-Art and Future Prospects.
    Sood A; Kumar A; Gupta VK; Kim CM; Han SS
    ACS Biomater Sci Eng; 2023 Jan; 9(1):62-84. PubMed ID: 36541361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current developments and applications of microfluidic technology toward clinical translation of nanomedicines.
    Liu D; Zhang H; Fontana F; Hirvonen JT; Santos HA
    Adv Drug Deliv Rev; 2018 Mar; 128():54-83. PubMed ID: 28801093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic Reconstitution of Tumor Microenvironment for Nanomedical Applications.
    Oh HJ; Kim J; Kim H; Choi N; Chung S
    Adv Healthc Mater; 2021 May; 10(9):e2002122. PubMed ID: 33576178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering and evaluating drug delivery particles in microfluidic devices.
    Björnmalm M; Yan Y; Caruso F
    J Control Release; 2014 Sep; 190():139-49. PubMed ID: 24794898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microfluidics for Cancer Nanomedicine: From Fabrication to Evaluation.
    Zhang H; Zhu Y; Shen Y
    Small; 2018 Jul; 14(28):e1800360. PubMed ID: 29806174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-Vessel-on-a-Chip Platforms for Evaluating Nanoparticle Drug Delivery Systems.
    Li Y; Zhu K; Liu X; Zhang YS
    Curr Drug Metab; 2018; 19(2):100-109. PubMed ID: 28952434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfluidic cell chips for high-throughput drug screening.
    Chi CW; Ahmed AR; Dereli-Korkut Z; Wang S
    Bioanalysis; 2016 May; 8(9):921-37. PubMed ID: 27071838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Merging microfluidics with luminescence immunoassays for urgent point-of-care diagnostics of COVID-19.
    Yuan H; Chen P; Wan C; Li Y; Liu BF
    Trends Analyt Chem; 2022 Dec; 157():116814. PubMed ID: 36373139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cells, tissues, and organs on chips: challenges and opportunities for the cancer tumor microenvironment.
    Young EW
    Integr Biol (Camb); 2013 Sep; 5(9):1096-109. PubMed ID: 23799587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Nanoparticles in Preclinical Research Using Microfluidic Systems.
    Zhu D; Long Q; Xu Y; Xing J
    Micromachines (Basel); 2019 Jun; 10(6):. PubMed ID: 31234335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic and lab-on-a-chip preparation routes for organic nanoparticles and vesicular systems for nanomedicine applications.
    Capretto L; Carugo D; Mazzitelli S; Nastruzzi C; Zhang X
    Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1496-532. PubMed ID: 23933616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish-on-a-chip: microfluidics for zebrafish research.
    Yang F; Gao C; Wang P; Zhang GJ; Chen Z
    Lab Chip; 2016 Apr; 16(7):1106-25. PubMed ID: 26923141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.